Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix C Popp

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Stem Cell Research & Therapy|January 29, 2008
Therapeutic potential of bone marrow stem cells for liver diseasesFelix C Popp, Pompiliu Piso, Hans J Schlitt, et al.
Current Opinion in Organ Transplantation|November 16, 2013
Rationale and prospects of mesenchymal stem cell therapy for liver transplantationNataša Obermajer, Felix C Popp, Christian L Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 30, 2004
Stem cell therapy of the liver--fusion or fiction?Marc H Dahlke, Felix C Popp, Stephen Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2014
Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapyNataša Obermajer, Felix C Popp, Yorick Soeder, et al.
Annals of Surgical Oncology|November 4, 2010
Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapyGabriel Glockzin, Philipp Renner, Felix C Popp, et al.
Transplantation|May 9, 2009
Mesenchymal stem cells can affect solid organ allograft survivalFelix C Popp, Elke Eggenhofer, Philipp Renner, et al.
Psychosomatics|March 16, 2005
Differences in attitude toward living and postmortal liver donation in the United States, Germany, and JapanMarc H Dahlke, Felix C Popp, Nadine Eggert, et al.
Transplantation|June 14, 2006
Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant modelSeiichiro Inoue, Felix C Popp, Gudrun E Koehl, et al.
Cancers|April 13, 2023
Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaKarl Knipper, Alexander I Damanakis, Yue Zhao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Mesenchymal stem cells as immunomodulators after liver transplantationFelix C Popp, Philipp Renner, Elke Eggenhofer, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Stem Cell Research & Therapy|January 29, 2008
Therapeutic potential of bone marrow stem cells for liver diseasesFelix C Popp, Pompiliu Piso, Hans J Schlitt, et al.
Current Opinion in Organ Transplantation|November 16, 2013
Rationale and prospects of mesenchymal stem cell therapy for liver transplantationNataša Obermajer, Felix C Popp, Christian L Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 30, 2004
Stem cell therapy of the liver--fusion or fiction?Marc H Dahlke, Felix C Popp, Stephen Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2014
Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapyNataša Obermajer, Felix C Popp, Yorick Soeder, et al.
Annals of Surgical Oncology|November 4, 2010
Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapyGabriel Glockzin, Philipp Renner, Felix C Popp, et al.
Transplantation|May 9, 2009
Mesenchymal stem cells can affect solid organ allograft survivalFelix C Popp, Elke Eggenhofer, Philipp Renner, et al.
Psychosomatics|March 16, 2005
Differences in attitude toward living and postmortal liver donation in the United States, Germany, and JapanMarc H Dahlke, Felix C Popp, Nadine Eggert, et al.
Transplantation|June 14, 2006
Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant modelSeiichiro Inoue, Felix C Popp, Gudrun E Koehl, et al.
Cancers|April 13, 2023
Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaKarl Knipper, Alexander I Damanakis, Yue Zhao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Mesenchymal stem cells as immunomodulators after liver transplantationFelix C Popp, Philipp Renner, Elke Eggenhofer, et al.
Pageof 5